BR112015013017A2 - dispositivos e métodos para perfurar uma cápsula para liberar um medicamento em pó a partir da mesma - Google Patents

dispositivos e métodos para perfurar uma cápsula para liberar um medicamento em pó a partir da mesma

Info

Publication number
BR112015013017A2
BR112015013017A2 BR112015013017A BR112015013017A BR112015013017A2 BR 112015013017 A2 BR112015013017 A2 BR 112015013017A2 BR 112015013017 A BR112015013017 A BR 112015013017A BR 112015013017 A BR112015013017 A BR 112015013017A BR 112015013017 A2 BR112015013017 A2 BR 112015013017A2
Authority
BR
Brazil
Prior art keywords
capsule
approximately
release
methods
devices
Prior art date
Application number
BR112015013017A
Other languages
English (en)
Other versions
BR112015013017B1 (pt
Inventor
Noble Brian
Ellwanger Colleen
Plunkett Sean
Coker Tim
Original Assignee
Civitas Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50824204&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112015013017(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Civitas Therapeutics Inc filed Critical Civitas Therapeutics Inc
Publication of BR112015013017A2 publication Critical patent/BR112015013017A2/pt
Publication of BR112015013017B1 publication Critical patent/BR112015013017B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A61M15/0035—Piercing means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A61M15/0041—Details of the piercing or cutting means with movable piercing or cutting means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

resumo “dispositivos e métodos para perfurar uma cápsula para liberar um medicamento em pó a partir da mesma” trata-se de um dispositivo para perfurar uma cápsula para liberar um medi-camento em pó a partir da mesma, o qual inclui uma câmara para receber a cápsula. a cápsula inclui abóbadas opostas e uma parede de parede cilíndrica definida por um raio de parede da cápsula r. o dispositivo adicionalmente inclui um mecanismo para perfurar pelo menos um furo em pelo menos uma dose. um centro de cada furo está localizado dentro de uma região de perfuração anular situada em não de menos de 0,4r, e uma área de superfície total de todos os furos perfurados está entre aproximadamente 0,5% e aproximadamente 2,2% de uma área de superfície total da cápsula. a região de perfuração anular pode, por exemplo, estar situada entre aproximadamente 0,4r e aproximadamente 0,8r, ou entre aproximadamente 0,4r e aproximadamente 0,6r.
BR112015013017-8A 2012-12-04 2013-12-03 Combinação de cápsula e dispositivo de inalação e método de utilizar uma combinação de cápsula e dispositivo de inalação BR112015013017B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261733117P 2012-12-04 2012-12-04
US61/733,117 2012-12-04
US13/719,598 US20140150787A1 (en) 2012-12-04 2012-12-19 Devices and methods for puncturing a capsule to release a powdered medicament therefrom
US13/719,598 2012-12-19
PCT/US2013/072769 WO2014089018A2 (en) 2012-12-04 2013-12-03 Devices and methods for puncturing a capsule to release a powdered medicament therefrom

Publications (2)

Publication Number Publication Date
BR112015013017A2 true BR112015013017A2 (pt) 2017-07-11
BR112015013017B1 BR112015013017B1 (pt) 2022-06-21

Family

ID=50824204

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015013017-8A BR112015013017B1 (pt) 2012-12-04 2013-12-03 Combinação de cápsula e dispositivo de inalação e método de utilizar uma combinação de cápsula e dispositivo de inalação

Country Status (19)

Country Link
US (4) US20140150787A1 (pt)
EP (3) EP2928530A2 (pt)
JP (5) JP2015536765A (pt)
KR (2) KR102416895B1 (pt)
CN (1) CN104981264B (pt)
AU (5) AU2013356299B2 (pt)
BR (1) BR112015013017B1 (pt)
CA (2) CA3209510A1 (pt)
DK (1) DK3090773T3 (pt)
ES (1) ES2760606T3 (pt)
FR (1) FR20C1011I1 (pt)
HK (1) HK1226012A1 (pt)
MX (2) MX2015007115A (pt)
NZ (1) NZ708449A (pt)
PL (1) PL3090773T3 (pt)
PT (1) PT3090773T (pt)
RU (1) RU2677766C2 (pt)
SG (1) SG11201504387UA (pt)
WO (1) WO2014089018A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150080786A1 (en) * 2013-09-16 2015-03-19 Robert E. King Compact Consciousness Arousing Device
US11491288B2 (en) 2014-01-08 2022-11-08 Seroton, Inc. Dispenser for dry-powder inhalation devices
US10238820B2 (en) 2014-01-08 2019-03-26 Seroton, Inc. Dry-powder inhalation device
USD755367S1 (en) 2014-03-10 2016-05-03 Civitas Therapeutics, Inc. Indicator for an inhaler
USD752734S1 (en) * 2014-03-10 2016-03-29 Civitas Therapeutics, Inc. Inhaler grip
USD752204S1 (en) 2014-03-10 2016-03-22 Civitas Therapeutics, Inc. Indicator for an inhaler
EP3548126B1 (en) * 2016-11-30 2021-07-14 Philip Morris Products S.A. Inhaler with sized cavity
CN106542161B (zh) * 2017-01-19 2018-04-20 朱兴春 一种收集胶囊药物的方法
IL269275B2 (en) * 2017-06-28 2023-04-01 Philip Morris Products Sa Container with particles for use with an inhaler
DE102018108958A1 (de) * 2018-04-16 2019-10-17 Emphasys Importadora Exportadora E Distribuidora Ltda. Trockenpulverinhalator

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1182779A (en) * 1966-09-17 1970-03-04 Fisons Pharmaceuticals Ltd Inhalation Device
US4069819A (en) * 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
US3927195A (en) * 1974-01-31 1975-12-16 Lilly Industries Ltd Production of capsules
IT1228460B (it) * 1989-02-23 1991-06-19 Phidea S R L Inalatore monouso con capsula pre-forata
WO1992007775A1 (fr) * 1990-10-31 1992-05-14 Coffea S.A. Procede de preparation d'un produit liquide et dispositif pour sa mise en ×uvre
CA2108768A1 (en) 1991-05-31 1992-12-01 Ralph R. Grosswald Method and apparatus for the manufacture of pharmaceutical cellulose capsules
PT101450B (pt) * 1994-02-02 1999-11-30 Hovione Produtos Farmaceuticos Novo dispositivo para inalacao
US5897880A (en) * 1995-09-29 1999-04-27 Lam Pharmaceuticals, Llc. Topical drug preparations
US6007843A (en) * 1995-09-29 1999-12-28 Lam Pharmaceuticals Corp. Sustained release delivery system
BR9807262A (pt) * 1997-02-21 2000-05-23 Reynolds Tobacco Co R Composições farmacêuticas incorporando compostos de amina olefìnica substituìda com arila
ATE302597T1 (de) * 1997-06-06 2005-09-15 Depomed Inc Im magen verweilende orale dosierungsformen von wasserlöslichen arzneistoffen mit kontrollierter freisetzung
US6766799B2 (en) * 2001-04-16 2004-07-27 Advanced Inhalation Research, Inc. Inhalation device
ITMI20020078A1 (it) * 2002-01-16 2003-07-16 Fabrizio Niccolai Dispositivo utilizzabile nel tratamento di affezzioni delle vie respiratorie
EP2630954B1 (en) 2002-03-20 2016-10-05 Civitas Therapeutics, Inc. Pulmonary delivery for levodopa
CA2477653C (en) * 2002-03-20 2008-03-25 Advanced Inhalation Research, Inc. Puncturing means for use in an inhalation device
US20040206350A1 (en) * 2002-12-19 2004-10-21 Nektar Therapeutics Aerosolization apparatus with non-circular aerosolization chamber
US20050081852A1 (en) * 2002-12-30 2005-04-21 Nektar Therapeutics (Formely Inhale Therapeutic System Inc.) Package for an aerosolization apparatus and pharmaceutical formulation receptacle
US20050056280A1 (en) * 2002-12-31 2005-03-17 Nektar Therapeutics Receptacle for an aerosolizable pharmaceutical formulation
US7878193B2 (en) 2003-01-14 2011-02-01 Boehringer Ingelheim International Gmbh Capsule for taking an active substance which can be inhaled
US20060254583A1 (en) * 2003-03-20 2006-11-16 Arthur Deboeck Dry powder inhaler system
ES2872350T3 (es) * 2003-06-13 2021-11-02 Civitas Therapeutics Inc Polvos farmacéuticos de dosis baja para inhalación
EP1700548B2 (en) * 2004-10-25 2018-10-31 Nestec S.A. Beverage production system
RU2369411C2 (ru) * 2005-04-21 2009-10-10 Бёрингер Ингельхайм Интернациональ Гмбх Порошковый ингалятор
US8360057B2 (en) * 2006-03-10 2013-01-29 Dose One, Llc Medication inhaler for dispensing multiple capsules
WO2008156586A2 (en) * 2007-06-12 2008-12-24 Alkermes, Inc. Inhalation device for powdered substances
WO2009075794A1 (en) * 2007-12-05 2009-06-18 Nektar Therapeutics Receptacle for an aerosolizable pharmaceutical formulation
KR101752080B1 (ko) * 2007-12-28 2017-06-28 임팩스 라보라토리즈, 인코포레이티드 레보도파 방출 제어형 제제 및 이의 용도
EP2082768A1 (en) * 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
CN102574638A (zh) * 2009-08-28 2012-07-11 绿山咖啡烘培公司 使用助滤剂来形成饮料的饮料筒以及方法
JP7236257B2 (ja) * 2018-11-30 2023-03-09 三星電子株式会社 衣類乾燥機

Also Published As

Publication number Publication date
KR20210049984A (ko) 2021-05-06
AU2020250224B2 (en) 2022-02-03
WO2014089018A2 (en) 2014-06-12
BR112015013017B1 (pt) 2022-06-21
EP2928530A2 (en) 2015-10-14
WO2014089018A3 (en) 2014-08-07
EP3090773A2 (en) 2016-11-09
NZ708449A (en) 2019-09-27
KR20150100712A (ko) 2015-09-02
PT3090773T (pt) 2020-01-06
DK3090773T3 (da) 2019-12-09
KR102248068B1 (ko) 2021-05-04
PL3090773T3 (pl) 2020-05-18
HK1226012A1 (zh) 2017-09-22
AU2018204682B2 (en) 2019-04-11
CN104981264A (zh) 2015-10-14
AU2019204497B2 (en) 2020-07-16
JP2022133450A (ja) 2022-09-13
AU2018204682A1 (en) 2018-07-19
US20140150787A1 (en) 2014-06-05
KR102416895B1 (ko) 2022-07-05
RU2015126657A (ru) 2017-01-13
CA3209510A1 (en) 2014-06-12
AU2019204497A1 (en) 2019-07-11
JP2020127773A (ja) 2020-08-27
EP3090773B1 (en) 2019-09-18
EP3090773A3 (en) 2017-02-08
JP2015536765A (ja) 2015-12-24
AU2013356299A1 (en) 2015-06-11
AU2022202802B2 (en) 2024-02-15
FR20C1011I1 (fr) 2020-05-01
US20240198020A1 (en) 2024-06-20
AU2022202802A1 (en) 2022-05-19
MX2015007115A (es) 2016-03-31
EP3607986A3 (en) 2020-07-15
AU2013356299B2 (en) 2018-04-19
ES2760606T3 (es) 2020-05-14
CA2894031A1 (en) 2014-06-12
JP2018118062A (ja) 2018-08-02
AU2020250224A1 (en) 2020-11-05
US20180289904A1 (en) 2018-10-11
MX2020004877A (es) 2020-08-13
EP3607986A2 (en) 2020-02-12
SG11201504387UA (en) 2015-07-30
CA2894031C (en) 2023-10-03
RU2677766C2 (ru) 2019-01-21
JP2024057017A (ja) 2024-04-23
US20210244895A1 (en) 2021-08-12
CN104981264B (zh) 2018-04-03

Similar Documents

Publication Publication Date Title
BR112015013017A2 (pt) dispositivos e métodos para perfurar uma cápsula para liberar um medicamento em pó a partir da mesma
BR112015010497A2 (pt) abridor para fazer grandes aberturas em cápsulas
BR112015001040A2 (pt) cápsula para preparar uma bebida e sistema para preparar uma bebida
BR112015013648A2 (pt) receitas paramétricas para preparar bebida com cápsulas em um sistema de infusão centrífugo
BR112017006965A2 (pt) unidade de infusão para um dispositivo de produção de bebida, e, dispositivo de produção de bebida
BR112015027758A2 (pt) subconjunto de percurso de fluxo
PE20160032A1 (es) Sistema de transferencia
BR112018003845A2 (pt) auxiliares cirúrgicos com medicamentos afetados por materiais ativadores
BR112015022433A2 (pt) dispositivos de liberação de droga com componente permeável à droga e métodos
BR112016006188A2 (pt) método de tratamento com um protocolo de fármaco e um sistema com uma base de dados relacional acoplado a um ou mais dispositivos eletrônicos ; sistema para a gestão de um tratamento medicamentoso pela administração de um fármaco a um paciente e método de gestão de um tratamento com drogas usando um sistema de informação com uma base de dados relacional.
BR112015015981A2 (pt) integração de válvula de retenção esférica ao icd
AR103077A1 (es) Método para la producción de un sistema de administración farmacéutica
BR112018013419A2 (pt) arranjo de cápsula, sistema para preparar uma bebida e método para preparar uma bebida
BR112017001442A2 (pt) ?rolhas e métodos de liofilização e vedação de um medicamento?
BR112016014480A2 (pt) Bocal, tubular de furo de poço e método
BR112016010062A2 (pt) métodos e dispositivos de administração de fluido
BR112017024963A2 (pt) conjunto de agulha com filtro para seringa de injeção
BR112016016932A8 (pt) uso de uma combinação de oxaliplatina (oxa), leucovorina (lv) e 5-fluorouracil (5-fu)
BR112019002240A2 (pt) cápsula para preparação de bebidas por infusão e solúveis
CL2016001965A1 (es) Composición coadyuvante anticancerígena que contiene rip3 expresión del promotor como ingrediente activo, método para seleccionar composición coadyuvante anticancerígena para mejorar la sensibilidad de droga anticancerigena, promoviendo la expresión rip3, y metodo para seguimiento de sensibilidad; medicamento contra el cáncer
BR112015023187A2 (pt) inibidores de pirrolo[2,3 - b] piridina cdk9 kinase
DOP2019000072A (es) Composición farmacéutica con antagonista del receptor de mineralocorticoides y su uso
EA201600387A1 (ru) Дисперсная система доставки лекарственного вещества
BR112015032256A2 (pt) dispositivo com sistema terapêutico transdérmico e auxiliar de posicionamento e penetração
BR112018068650A2 (pt) sistema de detecção de pressão

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/12/2013, OBSERVADAS AS CONDICOES LEGAIS